1. Home
  2. PZG vs XGN Comparison

PZG vs XGN Comparison

Compare PZG & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Paramount Gold Nevada Corp.

PZG

Paramount Gold Nevada Corp.

HOLD

Current Price

$2.51

Market Cap

97.2M

ML Signal

HOLD

Logo Exagen Inc.

XGN

Exagen Inc.

HOLD

Current Price

$3.76

Market Cap

110.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PZG
XGN
Founded
1992
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Mining
Medical Specialities
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
97.2M
110.8M
IPO Year
2015
2014

Fundamental Metrics

Financial Performance
Metric
PZG
XGN
Price
$2.51
$3.76
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$11.17
AVG Volume (30 Days)
2.5M
473.4K
Earning Date
01-01-0001
04-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
38.06
EPS
N/A
N/A
Revenue
$330,259.00
N/A
Revenue This Year
N/A
$21.40
Revenue Next Year
N/A
$14.11
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.34
$2.67
52 Week High
$2.61
$12.23

Technical Indicators

Market Signals
Indicator
PZG
XGN
Relative Strength Index (RSI) 69.04 42.58
Support Level $1.05 N/A
Resistance Level $2.54 $7.29
Average True Range (ATR) 0.24 0.26
MACD 0.00 0.12
Stochastic Oscillator 87.26 73.33

Price Performance

Historical Comparison
PZG
XGN

About PZG Paramount Gold Nevada Corp.

Paramount Gold Nevada Corp is an exploration-stage mining company. Together with its subsidiaries, the company is engaged in the business of acquiring, exploring, and developing precious metal projects in the United States. Also, it explores for gold and silver. The company enhances the value of projects by implementing exploration and engineering programs that are likely to expand and upgrade known mineralized material to reserves. Its projects include sleeper gold, grassy mountain gold, frost project, other non-material, and others.

About XGN Exagen Inc.

Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.

Share on Social Networks: